Class information for:
Level 1: MULTIPLE MYELOMA//LENALIDOMIDE//BORTEZOMIB

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
337 3627 39.1 78%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
482 3       MULTIPLE MYELOMA//AMYLOIDOSIS//TRANSTHYRETIN 23544
713 2             MULTIPLE MYELOMA//MYELOMA//LENALIDOMIDE 12863
337 1                   MULTIPLE MYELOMA//LENALIDOMIDE//BORTEZOMIB 3627

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 MULTIPLE MYELOMA authKW 2653975 41% 21% 1503
2 LENALIDOMIDE authKW 1081260 9% 39% 326
3 BORTEZOMIB authKW 779495 11% 24% 392
4 THALIDOMIDE authKW 701099 10% 22% 372
5 MYELOMA authKW 512684 9% 18% 330
6 MYELOMA UNIT address 388875 2% 61% 76
7 POMALIDOMIDE authKW 329638 2% 64% 61
8 ELOTUZUMAB authKW 210736 1% 96% 26
9 IMMUNOMODULATORY DRUGS authKW 200887 2% 39% 62
10 AZIENDA OSPED S GIOVANNI BATTISTA address 163654 1% 59% 33

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Hematology 116878 54% 1% 1973
2 Oncology 28891 46% 0% 1679
3 Transplantation 5560 8% 0% 307
4 Immunology 850 9% 0% 330
5 Medicine, General & Internal 754 8% 0% 300
6 Pharmacology & Pharmacy 60 5% 0% 190
7 Cell & Tissue Engineering 53 0% 0% 16
8 Medicine, Research & Experimental 42 3% 0% 92
9 Education, Scientific Disciplines 11 0% 0% 18
10 Medical Laboratory Technology 9 1% 0% 19

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 MYELOMA UNIT 388875 2% 61% 76
2 AZIENDA OSPED S GIOVANNI BATTISTA 163654 1% 59% 33
3 HEMATOL 117451 23% 2% 829
4 JEROME LIPPER MULTIPLE MYELOMA 116709 2% 22% 62
5 SERAGNOLI HEMATOL 114151 1% 59% 23
6 MYELOMA THER Y 111355 2% 19% 70
7 EMATOL 88181 3% 12% 91
8 AZIENDA OSPED UNIV CITTA SALUTE SCI TORINO 82104 1% 51% 19
9 CLIN EMATOL 76255 1% 25% 37
10 JOHN THEURER CANC 65204 1% 22% 35

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 42403 2% 8% 62
2 BONE MARROW TRANSPLANTATION 41641 6% 2% 209
3 EUROPEAN JOURNAL OF HAEMATOLOGY 40685 4% 4% 136
4 CLINICAL LYMPHOMA & MYELOMA 30063 1% 11% 34
5 BRITISH JOURNAL OF HAEMATOLOGY 27885 6% 2% 212
6 LEUKEMIA & LYMPHOMA 20950 4% 2% 138
7 BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 18056 2% 3% 81
8 BLOOD 16431 7% 1% 261
9 EXPERT REVIEW OF HEMATOLOGY 12981 1% 5% 29
10 BLOOD CANCER JOURNAL 10265 1% 6% 19

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class		 LCSH search Wikipedia search
1 MULTIPLE MYELOMA 2653975 41% 21% 1503 Search MULTIPLE+MYELOMA Search MULTIPLE+MYELOMA
2 LENALIDOMIDE 1081260 9% 39% 326 Search LENALIDOMIDE Search LENALIDOMIDE
3 BORTEZOMIB 779495 11% 24% 392 Search BORTEZOMIB Search BORTEZOMIB
4 THALIDOMIDE 701099 10% 22% 372 Search THALIDOMIDE Search THALIDOMIDE
5 MYELOMA 512684 9% 18% 330 Search MYELOMA Search MYELOMA
6 POMALIDOMIDE 329638 2% 64% 61 Search POMALIDOMIDE Search POMALIDOMIDE
7 ELOTUZUMAB 210736 1% 96% 26 Search ELOTUZUMAB Search ELOTUZUMAB
8 IMMUNOMODULATORY DRUGS 200887 2% 39% 62 Search IMMUNOMODULATORY+DRUGS Search IMMUNOMODULATORY+DRUGS
9 NOVEL AGENTS 115886 1% 31% 45 Search NOVEL+AGENTS Search NOVEL+AGENTS
10 DARATUMUMAB 113621 0% 75% 18 Search DARATUMUMAB Search DARATUMUMAB

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 LAUBACH, J , GARDERET, L , MAHINDRA, A , GAHRTON, G , CAERS, J , SEZER, O , VOORHEES, P , LELEU, X , JOHNSEN, HE , STREETLY, M , ET AL (2016) MANAGEMENT OF RELAPSED MULTIPLE MYELOMA: RECOMMENDATIONS OF THE INTERNATIONAL MYELOMA WORKING GROUP.LEUKEMIA. VOL. 30. ISSUE 5. P. 1005 -1017 92 87% 7
2 MARTINO, M , RECCHIA, AG , FEDELE, R , NERI, S , VINCELLI, ID , MOSCATO, T , GENTILE, M , MORABITO, F , (2016) THE ROLE OF TANDEM STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA PATIENTS.EXPERT OPINION ON BIOLOGICAL THERAPY. VOL. 16. ISSUE 4. P. 515 -534 93 99% 2
3 SHAH, N , CALLANDER, N , GANGULY, S , GUL, Z , HAMADANI, M , COSTA, L , SENGSAYADETH, S , ABIDI, M , HARI, P , MOHTY, M , ET AL (2015) HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA: GUIDELINES FROM THE AMERICAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION.BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. VOL. 21. ISSUE 7. P. 1155 -1166 103 81% 16
4 SONNEVELD, P , BROIJL, A , (2016) TREATMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA.HAEMATOLOGICA. VOL. 101. ISSUE 4. P. 396 -406 91 93% 3
5 LONIAL, S , ANDERSON, KC , (2014) ASSOCIATION OF RESPONSE ENDPOINTS WITH SURVIVAL OUTCOMES IN MULTIPLE MYELOMA.LEUKEMIA. VOL. 28. ISSUE 2. P. 258-268 94 90% 29
6 BIRD, JM , OWEN, RG , D'SA, S , SNOWDEN, JA , PRATT, G , ASHCROFT, J , YONG, K , COOK, G , FEYLER, S , DAVIES, F , ET AL (2011) GUIDELINES FOR THE DIAGNOSIS AND MANAGEMENT OF MULTIPLE MYELOMA 2011.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 154. ISSUE 1. P. 32 -75 133 59% 115
7 JAKUBOWIAK, A , (2012) MANAGEMENT STRATEGIES FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: CURRENT CLINICAL PERSPECTIVES.SEMINARS IN HEMATOLOGY. VOL. 49. ISSUE 3. P. S16-S32 108 86% 17
8 HAHN, T , WINGARD, JR , ANDERSON, KC , BENSINGER, WI , BERENSON, JR , BROZEIT, G , CARVER, JR , KYLE, RA , MCCARTHY, PL , (2003) THE ROLE OF CYTOTOXIC THERAPY WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE THERAPY OF MULTIPLE MYELOMA: AN EVIDENCE-BASED REVIEW.BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. VOL. 9. ISSUE 1. P. 4-37 150 79% 47
9 RAJKUMAR, SV , KUMAR, S , (2016) MULTIPLE MYELOMA: DIAGNOSIS AND TREATMENT.MAYO CLINIC PROCEEDINGS. VOL. 91. ISSUE 1. P. 101 -119 74 67% 14
10 VAN DE DONK, NWCJ , LOKHORST, HM , DIMOPOULOS, M , CAVO, M , MORGAN, G , EINSELE, H , KROPFF, M , SCHEY, S , AVET-LOISEAU, H , LUDWIG, H , ET AL (2011) TREATMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA IN THE ERA OF NOVEL AGENTS.CANCER TREATMENT REVIEWS. VOL. 37. ISSUE 4. P. 266 -283 119 78% 24

Classes with closest relation at Level 1


Rank Class id link
1 2155 MULTIPLE MYELOMA//PLASMA CELL LEUKEMIA//MYELOMA
2 7173 THALIDOMIDE//CEREBLON//THALIDOMIDE ANALOGUES
3 22826 CORRELATION BIPLOT//ALTERED T CELL REPERTOIRE//AZIENDA OSPED SAN GIOVANNI BATTISTA DI TORINO
4 26758 BENDAMUSTINE//TREANDA//BENDAMUSTIN
5 6612 FREE LIGHT CHAINS//MONOCLONAL GAMMOPATHY//SERUM FREE LIGHT CHAINS
6 5140 PROTEASOME INHIBITOR//BORTEZOMIB//PROTEASOME
7 17458 MYELOMA BONE DISEASE//MULTIPLE MYELOMA//BONE DISEASE
8 7421 LIGHT CHAIN DEPOSITION DISEASE//FIBRILLARY GLOMERULONEPHRITIS//IMMUNOTACTOID GLOMERULOPATHY
9 5414 PLASMACYTOMA//EXTRAMEDULLARY PLASMACYTOMA//SOLITARY PLASMACYTOMA
10 26333 IGD RECEPTOR//IGD MYELOMA//IGD

Go to start page